Discovery of heterocycle-containing α-naphthoflavone derivatives as water-soluble, highly potent and selective CYP1B1 inhibitors

被引:24
|
作者
Dong, Jinyun [1 ,2 ,4 ]
Huang, Guang [1 ]
Cui, Qing [1 ]
Meng, Qingqing [1 ]
Li, Shaoshun [1 ]
Cui, Jiahua [1 ,3 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Pharm, 800 Dongchuan Rd, Shanghai, Peoples R China
[2] Zhejiang Chinese Med Univ, Coll Pharmaceut Sci, Hangzhou, Peoples R China
[3] Shanghai Jiao Tong Univ, Sch Environm Sci & Engn, 800 Dongchuan Rd, Shanghai, Peoples R China
[4] Chinese Acad Sci, Inst Canc & Basic Med, Hangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
CYP1; enzymes; CYP1B1; inhibitors; alpha-Naphthoflavone derivatives; SARs; DNA ADDUCT FORMATION; DESIGN; RESISTANCE; EXPRESSION; ANALOGS;
D O I
10.1016/j.ejmech.2020.112895
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Cytochrome P450 1B1 (CYP1B1) has been well validated as an attractive target for cancer prevention and drug resistance reversal. In continuation of our interest in this area, herein, a set of forty-six 6,7,10-trimethoxy-alpha-naphthoflavone derivatives varying in B ring was synthesized and screened against CYP1 enzymes, leading to the identification of fluorine-containing compound 15i as the most potent and selective CYP1B1 inhibitor (IC50 value of 0.07 nM), being 84-fold more potent than that of the template molecule ANF. Alternatively, the amino-substituted derivative 13h not only possessed a potent inhibitory effect on CYP1B1 (IC50 value of 0.98 nM), but also had a substantially increased water solubility as compared with the lead ANF (311 mu g/mL for 13h and <5 mu g/mL for ANF). The current study expanded the structural diversity of CYP1B1 inhibitors, and compound 13h could be considered as a promising starting point with great potential for further studies. (c) 2020 Elsevier Masson SAS. All rights reserved.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Synthesis and structure-activity relationship studies of α-naphthoflavone derivatives as CYP1B1 inhibitors
    Dong, Jinyun
    Wang, Zengtao
    Cui, Jiahua
    Meng, Qingqing
    Li, Shaoshun
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 187
  • [2] Quinazoline derivatives as selective CYP1B1 inhibitors
    Siddique, Mohd Usman Mohd
    McCann, Glen J. P.
    Sonawane, Vinay R.
    Horley, Neill
    Gatchie, Linda
    Joshi, Prashant
    Bharate, Sandip B.
    Jayaprakash, Venkatesan
    Sinha, Barij N.
    Chaudhuri, Bhabatosh
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 130 : 320 - 327
  • [3] Design, synthesis and biological evaluation of highly potent and selective CYP1B1 inhibitors
    Zhang, Haoyu
    Xu, Ping
    Wang, Ting
    Wang, Shiyu
    Li, Weixia
    Mao, Jianping
    Wang, Jian
    Zhang, Fengjiao
    Cheng, Maosheng
    NEW JOURNAL OF CHEMISTRY, 2023, 47 (12) : 5680 - 5690
  • [4] Scaffold hopping for designing of potent and selective CYP1B1 inhibitors to overcome docetaxel resistance: synthesis and evaluation
    Raju, Baddipadige
    Narendra, Gera
    Verma, Himanshu
    Kumar, Manoj
    Sapra, Bharti
    Kaur, Gurleen
    Jain, Subheet Kumar
    Sandeep Chary, Padakanti
    Mehra, Neelesh Kumar
    Silakari, Om
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2024,
  • [5] Biphenyl urea derivatives as selective CYP1B1 inhibitors
    Siddique, Mohd Usman Mohd
    McCann, Glen J. P.
    Sonawane, Vinay
    Horley, Neill
    Williams, Ibidapo Steven
    Joshi, Prashant
    Bharate, Sandip B.
    Jayaprakash, Venkatesan
    Sinha, Barij N.
    Chaudhuri, Bhabatosh
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2016, 14 (38) : 8931 - 8936
  • [6] Development of benzochalcone derivatives as selective CYP1B1 inhibitors and anticancer agents
    Dong, Jinyun
    Huang, Guang
    Zhang, Qijing
    Wang, Zengtao
    Cui, Jiahua
    Wu, Yan
    Meng, Qingqing
    Li, Shaoshun
    MEDCHEMCOMM, 2019, 10 (09) : 1606 - 1614
  • [7] Design and synthesis of new alfa-naphthoflavanones as potent and selective CYP1B1 inhibitors
    Feng, Shiyin
    Qin, Weiwei
    Xiang, Shouyan
    Zhang, Xu
    Cui, Jiahua
    NATURAL PRODUCT RESEARCH, 2024,
  • [8] Discovery and characterization of novel CYP1B1 inhibitors based on heterocyclic chalcones: Overcoming cisplatin resistance in CYP1B1-overexpressing lines
    Horley, Neill J.
    Beresford, Kenneth J. M.
    Chawla, Tarun
    McCann, Glen J. P.
    Ruparelia, Ketan C.
    Gatchie, Linda
    Sonawane, Vinay R.
    Williams, Ibidapo S.
    Tan, Hoon L.
    Joshi, Prashant
    Bharate, Sonali S.
    Kumar, Vikas
    Bharate, Sandip B.
    Chaudhuri, Bhabatosh
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 129 : 159 - 174
  • [9] 3D-QSAR assisted identification of selective CYP1B1 inhibitors: an effective bioisosteric replacement/molecular docking/electrostatic complementarity analysis
    Raju, Baddipadige
    Sapra, Bharti
    Silakari, Om
    MOLECULAR DIVERSITY, 2023, 27 (06) : 2673 - 2693
  • [10] Bioflavonoids: selective substrates and inhibitors for cytochrome P450CYP1A and CYP1B1
    Doostdar, H
    Burke, MD
    Mayer, RT
    TOXICOLOGY, 2000, 144 (1-3) : 31 - 38